Scientific Data: In the OASIS 4 trial, 74% of participants experienced at least one gastrointestinal side effect
Across Cam3.II R539T and Cam3.II C580Y , compared to their isogenic sensitive isolate Cam3.II REV (isolates from Pursat Province, Cambodia) in both 3-6 hpi ring-(Fig 1) and in 24 hpi trophozoite-stage parasites (previously published) 9 , we found three proteins to be consistently dysregulated in abundance
Takeaways for Employers and Benefit Consultants As GLP-1 medications continue to reshape consumer behavior, benefit consultants have a unique opportunity to lead the conversation: Reevaluate coverage for GLP-1 medications, especially as their benefits extend beyond weight loss
doi: 10.1007/s00125-017-4447-4 7 GokeRFehmannHCLinnTSchmidtHKrauseMEngJet al
Sustained over years, this deficit has been linked to the early biological processes associated with Alzheimer's disease, which affects women at roughly twice the rate of men